|
Siemens Warned on Unapproved Immunoassay, Documentation Woes
Siemens Healthcare Diagnostics has come under FDA scrutiny after an inspection at its Tarrytown, N.Y., plant found the company was marketing a diagnostic test that had never been officially approved.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives